Rheumatoid arthritis (RA)
- Start a disease-modifying drug early
- Methotrexate is usual anchor for active RA
- Treat-to-target: remission or low disease activity
- Inadequate response → biologic/targeted DMARD
- Short steroid bridge only when necessary
- Screen infection/vaccines before immunosuppression
- NSAIDs help pain but do not prevent joint damage
Use at a glance
- Start a disease-modifying drug early
Practical pearls
- Screen infection/vaccines before immunosuppression
Other practical pearls
- Methotrexate is usual anchor for active RA
- Treat-to-target: remission or low disease activity
- Inadequate response → biologic/targeted DMARD
Choosing treatment
- Short steroid bridge only when necessary
Safety / pitfalls
- NSAIDs help pain but do not prevent joint damage
Self-check
- What should be started in Rheumatoid arthritis (RA)?
a disease-modifying drug early.
- What is recommended for Inadequate response in Rheumatoid arthritis (RA)?
biologic/targeted DMARD.
Drugs used for this (12)
All clinical uses · Open the interactive console ↗
